Taminadenant
5-bromo-2,6-di(pyrazol-1-yl)pyrimidin-4-amine
Molecular Identity
Taminadenant
5-bromo-2,6-di(pyrazol-1-yl)pyrimidin-4-amine
PubChem CID: 53466958
2D Structure
Properties
C10H8BrN7
Molecular Formula
306.12
Molecular Weight
g/mol
305.0025
Exact Mass
Da
1.2
XLogP
Drug-like (Lipinski: < 5)
87.4
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
5
H-Bond Acceptors
291
Complexity
SMILES
Canonical SMILES
SMILES: C1=CN(N=C1)C2=NC(=NC(=C2Br)N)N3C=CC=N3Isomeric SMILES
SMILES: C1=CN(N=C1)C2=NC(=NC(=C2Br)N)N3C=CC=N3Synonyms(20)
Taminadenant1337962-47-684I5UEP321PF-5094-Pyrimidinamine, 5-bromo-2,6-di-1H-pyrazol-1-yl-taminadenantumRefChem:1099388A2AR Antagonist PBF-5095-bromo-2,6-di(1H-pyrazol-1-yl)pyrimidin-4-aminePBF-509C10H8BrN75-bromo-2,6-di(pyrazol-1-yl)pyrimidin-4-amineMFCD30489281Taminadenant [INN]TAMINADENANT [WHO-DD]
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Taminadenant
Loading drug network...